Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers. - Wikidata - wikimedia - TriplyDB

Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers.

Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers.

http://www.wikidata.org/entity/Q37432987

about

Autoantibodies response to MDM2 and p53 in the immunodiagnosis of esophageal squamous cell carcinoma.

P2860

Q38981242-228B2D05-415D-432B-A389-EA81B63EB09E

P2860

Serum p53 Antibody Is Not Associated with p53 Immunoreactivity in Patients with Pancreatobiliary Cancers.

http://www.wikidata.org/entity/Q37432987

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Serum p53 Antibody Is Not Asso ...... with Pancreatobiliary Cancers.

@en

Serum p53 Antibody Is Not Asso ...... with Pancreatobiliary Cancers.

@nl

type

label

Serum p53 Antibody Is Not Asso ...... with Pancreatobiliary Cancers.

@en

Serum p53 Antibody Is Not Asso ...... with Pancreatobiliary Cancers.

@nl

prefLabel

Serum p53 Antibody Is Not Asso ...... with Pancreatobiliary Cancers.

@en

Serum p53 Antibody Is Not Asso ...... with Pancreatobiliary Cancers.

@nl

P1433

Q37432987-6818FD09-5C1D-4EBC-8D6E-0AE7092E238F

P1476

Q37432987-3C989B09-E058-4C9A-85F2-90D47F01516B

P2093

Q37432987-076573D8-8E13-47A9-8CCF-22DD6EAB5174

Q37432987-098BC552-AB27-49C3-87B2-9F7B10C9BC6D

Q37432987-13A9D00F-B90B-4CE1-81D4-D151F10E5AEA

Q37432987-14E9AE7E-CBEB-49B5-8840-3B218589E9F5

Q37432987-1EA9AAAC-9AFC-485F-A85A-1E288CBFBFE0

Q37432987-2A0D2C17-BD5E-4FB5-A6CE-0468F90D9E9E

Q37432987-31F89916-A0B0-410D-81DC-A36E680F8B96

Q37432987-4972D729-C846-46B9-9C41-C2FB35C6FED1

Q37432987-4D6DBA47-27B2-413C-8F3F-D049FDA7CF54

Q37432987-6C1DFB91-C9C5-44B8-8006-BDBD60DE3829

P2860

Q37432987-01272D8A-477C-4E73-89DC-D2D4F886FE24

Q37432987-12CC358A-B242-4A30-9E88-707933E2CA88

Q37432987-15104036-8E4B-471E-9FA3-FFCE918A55D3

Q37432987-1B7BFFB4-37F0-497B-9BB4-1281EB99A346

Q37432987-286F136E-2E8C-4109-90CD-9DD6255347EC

Q37432987-28833F64-2DB9-4B8B-AADE-BB67C550C573

Q37432987-2E64639A-2871-4CF4-94E0-C70F004EEC21

Q37432987-37DC8A8F-287B-412D-9E7F-BE9308224CB2

Q37432987-46861EE1-5A53-483D-AAC4-ED12FE09F0C4

Q37432987-4ABB934F-57F3-422A-BCE2-C165525A0911

P304

Q37432987-D34C7698-9B8D-48D6-8A04-FAB51989C16D

P31

Q37432987-91242A1E-52B5-49C5-B0C2-011D1B53EB11

P356

Q37432987-E9473DD2-4F97-4055-B35A-65390817EFE6

P478

Q37432987-950609E6-0371-475A-9CFA-65DC5AF390F0

P50

Q37432987-88BC406E-4CCD-4E1E-B5D5-D353F2342D66

P577

Q37432987-0AC09B28-8245-45AD-B256-C10848DC393A

P5875

Q37432987-F1F3968A-250C-4D78-BFF3-3FCEB6A28CA4

P698

Q37432987-DE36CFF9-0968-491E-98BC-531320A1B9BD

P932

Q37432987-A75DF904-75D5-4934-BC05-D17C3666BD72

P356

P1433

Journal of oncology

P1476

Serum p53 Antibody Is Not Asso ...... with Pancreatobiliary Cancers.

@en

P2093

Atsushi Sofuni

http://www.w3.org/2001/XMLSchema#string

Fumihide Itokawa

http://www.w3.org/2001/XMLSchema#string

Fuminori Moriyasu

http://www.w3.org/2001/XMLSchema#string

Junko Umeda

http://www.w3.org/2001/XMLSchema#string

Kentaro Ishii

http://www.w3.org/2001/XMLSchema#string

Mitsuyoshi Honjo

http://www.w3.org/2001/XMLSchema#string

Nobuhito Ikeuchi

http://www.w3.org/2001/XMLSchema#string

Reina Tanaka

http://www.w3.org/2001/XMLSchema#string

Ryosuke Tonozuka

http://www.w3.org/2001/XMLSchema#string

Shujiro Tsuji

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in the p53 gene occur in diverse human tumour types

Cancer. p53, guardian of the genome

Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

The p53 tumor suppressor gene: from molecular biology to clinical investigation.

Carcinoma of the pancreas and papilla of Vater: presenting symptoms, signs, and diagnosis related to stage and tumour site. A prospective multicentre trial in 472 patients. Norwegian Pancreatic Cancer Trial.

p53 mutations in pancreatic carcinoma and evidence of common involvement of homocopolymer tracts in DNA microdeletions.

Pancreatic adenocarcinomas frequently show p53 gene mutations.

Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.

Prognostic molecular markers in cholangiocarcinoma: a systematic review.

P304

170625

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2013/170625

http://www.w3.org/2001/XMLSchema#string

P478

2013

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259878954

http://www.w3.org/2001/XMLSchema#string

P698

24454372

http://www.w3.org/2001/XMLSchema#string

P932

3880693

http://www.w3.org/2001/XMLSchema#string